Anti-nucleosome antibody in sclerodema patients.

Sir,

Nucleosomes are considered to be the basic element of chromatin. These are formed by 200 ± 40 base pairs segment of DNA wrapped around the (H2A-H2B, H3-H4)2 histone octamer with histone H1 bound on the outside1. These may become immunogenic, triggering the production of autoantibodies under particular conditions such as presence of drug interactions or infections1.

Even though nucleosomes are considered to be the main antigens in the pathophysiology of systemic lupus erythematosus (SLE), some investigators have also found these in systemic sclerosis (SSc). This finding has been an interesting point of discussion because of the discrepancies in results. Wallace et al1 observed high frequencies of these autoantibodies in scleroderma patients with limited and diffuse form of this disease. Amoura et al2 detected these in 45.9 per cent of 37 scleroderma patients and Quattrocchi et al 3 in 36.3 per cent of 11 patients. On the other hand, Hmida et al 4 studying 49 SSc patients found only one positive patient similar to Cervera et al 5 who showed one positive in 10 SSc patients. These discrepancies have been attributed to different detection methods used. Binding of anti-Scl-70 to chromatin6 and the patient’s ethnic background may also account for these differences.

We studied anti-nucleosome antibodies in 54 consecutive SSc patients in a cross-sectional study at Evangelic University Hospital, Parana, Brazil during February to December 2009 was approved by the local Ethical Research Committee. All 54 investigated patients fulfilled the American College of Rheumatology (ACR) preliminary criteria for SSc7. In this group, 40 (7.4%) had limited form, 10 (18.6%) had generalized and 4 (74%) had PM-SSc (scleroderma-polimyositis) form. Patients with lupus mixed features (n=2) were excluded. Four patients were males and 50 female with mean age of 49.2 ± 12.7 yr. Interstitial lung disease was documented in 17 of 52 (32.7%). Anti-Scl-70 antibodies were found in 7 patients (13.4%).

After written consent, blood (5 ml) was collected from each patient. Samples were centrifuged for 10 min at 10000 g and serum separated, aliquoted and stored at -80°C until used. The detection of anti-nucleosome antibodies was done by ELISA using nucleosomes extracted from calf thymus chromatin as antigen (Inova Diagnostics Inc, USA). The cut-off point was of 20.0 U/ml, in accordance with manufacturer instructions. Data were analyzed through frequency tables and contingency tables using χ2 and Fisher tests with help of the software Graph Pad Prism, version 4.0 and adopting significance of 5 per cent.

Of the 54 patients tested, five (9.2%) were anti-nucleosome positive. Of these five, one was with PM-SSc form and four with limited form and none in the diffuse form. Values ranged between 36 to 151 UI/ml (mean 67 ± 38.8). No association was found between the presence anti-nucleosome antibodies and lung fibrosis or with presence of Scl-70.

In conclusion, our findings show that scleroderma should be considered a possibility while searching for the exact diagnosis of a connective tissue disease in a patient positive for anti-nucleosome antibodies. More research will be necessary to clarify the role of finding these autoantibodies in SSc.